Stroke Update: 위험인자 및 일차예방

키워드

참고문헌 (40)

1. The writing group of clinical practice guideline for stroke, "Clinical Practice Guideline for Stroke. 1st ed" (2009), Clinical Research Center for Stroke
2. O’Donnell MJ, "Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study", Lancet, 376, pp.112~123 (2010)
3. Farrell B, "The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: fi nal results", J Neurol Neurosurg Psychiatry, 54, pp.1044~1054 (1991)
4. The ESPS Group, "The European Stroke Prevention Study (ESPS). Principal end-points", Lancet, 330, pp.1351~1354 (1987)
5. The Dutch TIA Study Group, "A comparison of two doses of aspirin(30mg vs 283mg a day) in patients after a transient ischaemic attackor minor ischaemic stroke", N Engl J Med, 325, pp.1261~1266 (1991)
6. Dahlöf B, "ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendrofl umethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial", Lancet, 366, pp.895~906 (2005)
7. Rothwell PM, "Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension", Lancet, 375, pp.895~905 (2010)
8. Webb AJS, "Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis", Lancet, 375, pp.906~915 (2010)
9. Nathan DM, "Diabetes Control and Complications Trial", Epidemiology of Diabetes Interventions and Complications (DCCT, N Engl J Med, pp.2005, 353[DOI]
10. Patel A, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes", N Engl J Med, 358, pp.2560~2572 (2008)
11. Duckworth W, "Glucose control and vascular complications in veterans with type 2 diabetes", N Engl J Med, 360, pp.129~139 (2009)
12. Gerstein HC, "Effects of intensive glucose lowering in type 2 diabetes", N Engl J Med, 358, pp.2545~2559 (2008)
13. Holman RR, "10- year follow-up of intensive glucose control in type 2 diabetes", N Engl J Med, 359, pp.1577~1589 (2008)
14. Skylar JS, "Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientifi c statement of the American College of Cardiology Foundation and the American Heart Association", Criculation, 119, pp.351~357 (2009)
15. Baigent C, "Effi cacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins", Lancet, 366, pp.1267~1278 (2005)
16. Amarenco P, "High-dose atorvastatin after stroke or transient ischemic attack", N Engl J Med, 355, pp.549~559 (2006)
17. Amarenco P, "Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention", Lancet Neurol, 8, pp.453~463 (2009)
18. Brott TG, "CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis", N Engl J Med, 363, pp.11~23 (2010)
19. Howard VJ, "Influence of sex on outcomes ofstenting versus endarterectomy: a subgroup analysis of the CarotidRevascularization Endarterectomy versus Stenting Trial (CREST)", Lancet Neurol, 10, pp.530~537 (2011)
20. Hobson RW II, "Effi cacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group", N Engl J Med, 328, pp.221~227 (1993)
21. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study, "Endarterectomy for asymptomatic carotid artery stenosis", JAMA, 273, pp.1421~1428 (1995)
22. Halliday A, "Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial", Lancet, 363, pp.1491~1502 (2004)
23. Chambers BR, "Carotid endarterectomy for asymptomatic carotid stenosis", Cochrane Database Syst Rev (2005)
24. Abbott AL, "Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis", Stroke, 40, pp.573~583 (2009)
25. Marquardt L, "Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study", Stroke, 41, pp.11~17 (2010)
26. Woo K, "Contemporary results of carotid endarterectomy for asymptomatic carotid stenosis", Stroke, 41, pp.975~979 (2010)
27. Goessens BMB, "Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study", Stroke, 38, pp.1470~1475 (2007)
28. Toole JF, "Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention (VISP) randomised controlled trial", JAMA, 291, pp.565~575 (2004)
29. The VITATOPS Trial Study Group, "B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial", Lancet Neurol, 9, pp.855~865 (2010)
30. Zhang Y, "Lifestyle factors on the risks of ischemic and hemorrhagic stroke", Arch Intern Med, 171, pp.1811~1818 (2011)
31. Paik Myunghee Cho, "Lower prevalence of silent brain infarcts in the physically active The Northern Manhattan Study", NEUROLOGY, 76(24), pp.2112~2118, LIPPINCOTT WILLIAMS WILKINS
32. Belch J, "The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease", BMJ, 337, pp.1840~ (2008)
33. Ogawa H, "Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial", JAMA, 300, pp.2134~2141 (2008)
34. Fowkes FG, "Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial", JAMA, 303, pp.841~848 (2010)
35. De Berardis G, "Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials", BMJ, 339, pp.4531~ (2009)
36. Berger JS, "Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials", JAMA, 301, pp.1909~1919 (2009)
37. Baigent C, "Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials", Lancet, 373, pp.1849~1860 (2009)
38. Zhang C, "Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis", Diabetes Res Clin Pract, 87, pp.211~218 (2010)
39. Goldstein LB, "Guidelines for the Primary Prevention of Stroke. A Guideline for Healthcare Professionals From the American Heart Association", American Stroke Association, 2011, pp.42, 517~584
40. 구자성, "한국뇌졸중진료지침에서 아스피린의 뇌졸중 일차예방효과에 관한 내용의 부분개정", 대한신경과학회지, 29(4), pp.277~284 (2011), 대한신경과학회

관련 논문AI추천